CVRx, Inc.
NasdaqGS:CVRX
Sector
Location
Market Cap
USD 217.45 M
Share Price
USD 8.34
Avg Daily Volume
361,050
Change (1 day)
1.83%
Change (1 year)
-12.49%
Change (YTD)
-34.17%
CVRx, Inc. Balance Sheet 2019 - 2024
This table shows the Balance Sheet for CVRx, Inc. going from 2019 until 2024. The balance sheet is a financial statement that presents the financial position of a company at a specific point in time, typically at the end of a fiscal period. It consists of three main components: assets (such as cash, inventory, property, and investments), liabilities (including debts, loans, and obligations), and shareholders' equity (the residual interest in the company's assets after deducting liabilities). The balance sheet provides insights into a company's liquidity, solvency, and overall financial health.
Balance Sheet
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Edwards Lifesciences Corporation
USD 80.00
EW
+4.20
5.54%
GE HealthCare Technologies Inc.
USD 77.61
GEHC
+0.84
1.09%
DexCom, Inc.
USD 88.99
DXCM
+2.25
2.59%
Laboratory Corporation of America Holdings
USD 264.96
LH
-2.73
-1.02%
Natera, Inc.
USD 138.90
NTRA
-2.17
-1.54%
Baxter International Inc.
USD 29.22
BAX
+0.45
1.56%
Hologic, Inc.
USD 66.50
HOLX
+0.40
0.60%
Fisher & Paykel Healthcare Corporation Limited
USD 21.83
FPH.NZ
-0.07
-0.33%
Exact Sciences Corporation
USD 48.49
EXAS
-0.28
-0.57%
Penumbra, Inc.
USD 233.10
PEN
+2.92
1.27%
ConvaTec Group Plc
USD 3.22
CTEC.L
-0.06
-1.98%
Hangzhou Tigermed Consulting Co., Ltd.
USD 6.68
3347.HK
+0.28
4.38%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.97
300832.SZ
-0.03
-0.44%